Literature DB >> 23351390

Characteristics of neutralizing antibodies to adenovirus capsid proteins in human and animal sera.

Bin Yu1, Jianing Dong, Chu Wang, Yang Zhan, Haihong Zhang, Jiaxin Wu, Wei Kong, Xianghui Yu.   

Abstract

Although it is known that Ad5-specific neutralizing antibodies (NAbs) against three major viral capsid components (hexon, penton and fiber) are generated, differences in the frequency and nature of these pre-existing NAbs remain unclear. The results emphasized the contribution of anti-fiber antibodies to Ad5 neutralization responses generated during natural viral infection. Additionally, Ad5-specific NAbs against the fiber knob protein were present in over 90% of the positive serum samples while 42% of the sera had NAbs against hexon in this study based on neutralization assay of anti-HVR and anti-knob subtracted sera and Western blotting analysis. We also found that the trimeric knob was preferentially recognized by fiber-induced NAbs and it was serotype-specific in human adenovirus species C. Results indicated that the trimeric knob protein would be a good candidate antigen for detecting adenovirus serotype-specific NAbs in naturally infected sera.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23351390     DOI: 10.1016/j.virol.2012.12.014

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  20 in total

1.  Antigenic variability among two subtypes of human adenovirus serotype 7.

Authors:  Xingui Tian; Xiaobo Su; Chunyan Xue; Xiao Li; Zhichao Zhou; Rong Zhou
Journal:  Virus Genes       Date:  2014-04-24       Impact factor: 2.332

Review 2.  Vaccine development for human mastadenovirus.

Authors:  Shiying Chen; Xingui Tian
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

3.  Molecular evolution of human adenovirus type 16 through multiple recombination events.

Authors:  Xingui Tian; Hongkai Wu; Rong Zhou
Journal:  Virus Genes       Date:  2019-08-05       Impact factor: 2.332

Review 4.  Circumventing antivector immunity: potential use of nonhuman adenoviral vectors.

Authors:  Estrella Lopez-Gordo; Iva I Podgorski; Nicholas Downes; Ramon Alemany
Journal:  Hum Gene Ther       Date:  2014-03-25       Impact factor: 5.695

5.  Human Adenovirus Serotype 3 Vector Packaged by a Rare Serotype 14 Hexon.

Authors:  Xiaobo Su; Xingui Tian; Zaixue Jiang; Qiang Ma; Qian Liu; Xiaomei Lu; Rong Zhou
Journal:  PLoS One       Date:  2016-06-21       Impact factor: 3.240

6.  Identification and Application of Neutralizing Epitopes of Human Adenovirus Type 55 Hexon Protein.

Authors:  Xingui Tian; Qiang Ma; Zaixue Jiang; Junfeng Huang; Qian Liu; Xiaomei Lu; Qingming Luo; Rong Zhou
Journal:  Viruses       Date:  2015-10-27       Impact factor: 5.048

7.  Identification of a Critical and Conformational Neutralizing Epitope in Human Adenovirus Type 4 Hexon.

Authors:  Xingui Tian; Hongling Qiu; Zhichao Zhou; Shouli Wang; Ye Fan; Xiao Li; Ruiai Chu; Haitao Li; Rong Zhou; Hui Wang
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

Review 8.  Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma.

Authors:  Wojciech K Panek; J Robert Kane; Jacob S Young; Aida Rashidi; Julius W Kim; Deepak Kanojia; Maciej S Lesniak
Journal:  Oncotarget       Date:  2017-09-11

9.  A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model.

Authors:  Julius W Kim; J Robert Kane; Wojciech K Panek; Jacob S Young; Aida Rashidi; Dou Yu; Deepak Kanojia; Tanwir Hasan; Jason Miska; Miguel A Gómez-Lim; Ilya V Ulasov; Irina V Balyasnikova; Atique U Ahmed; Derek A Wainwright; Maciej S Lesniak
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

10.  Engineered adenovirus fiber shaft fusion homotrimer of soluble TRAIL with enhanced stability and antitumor activity.

Authors:  J Yan; L Wang; Z Wang; Z Wang; B Wang; R Zhu; J Bi; J Wu; H Zhang; H Wu; B Yu; W Kong; X Yu
Journal:  Cell Death Dis       Date:  2016-06-23       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.